Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1.

about

The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain.

P2860

Q38600704-0BBD8346-85E2-4157-943D-E587AC329182

P2860

Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1.

Item

http://www.wikidata.org/entity/Q36931310

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Cannabinoid WIN‑55,212‑2 mesyl ...... ting expression of syndecan‑1.

@en

type

Item

label

Cannabinoid WIN‑55,212‑2 mesyl ...... ting expression of syndecan‑1.

@en

prefLabel

Cannabinoid WIN‑55,212‑2 mesyl ...... ting expression of syndecan‑1.

@en

P1476

Cannabinoid WIN‑55,212‑2 mesyl ...... ting expression of syndecan‑1.

@en

P2093

Changjie Zhang

http://www.w3.org/2001/XMLSchema#string

Wanchun Wang

http://www.w3.org/2001/XMLSchema#string

Xiaorong Zhou

http://www.w3.org/2001/XMLSchema#string

Yang Liu

http://www.w3.org/2001/XMLSchema#string

Yi Wu

http://www.w3.org/2001/XMLSchema#string

Ying Kong

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II

ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate

Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5.

Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis.

Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease.

The endogenous proteoglycan-degrading enzyme ADAMTS-4 promotes functional recovery after spinal cord injury.

Syndecans: new kids on the signaling block.

Cannabinoids and PPARalpha signalling.

P304

4569-4576

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MMR.2016.5137

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27082728

http://www.w3.org/2001/XMLSchema#string

P921

cannabinoids

osteoarthritis

P932

4878569

http://www.w3.org/2001/XMLSchema#string

Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1.

about

P2860

P2860

Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932